Lundbeck cuts 1,000 jobs
Danish drugmaker Lundbeck has announced plans to slash 1,000 jobs as part of a massive restructuring.
Danish drugmaker Lundbeck has announced plans to slash 1,000 jobs as part of a massive restructuring.
There’s little chance US companies will consider Iran as a venue for pharmaceutical contract manufacturing, even in the current era of limited détente between the two countries, experts say.
Hemispherx Biopharma has signed extended US distribution agreements as part of efforts to relaunch Alferon N Injection, a genital wart treatment it pulled in 2008 after production costs soared.
Pakistani pharmaceutical manufacturers are today halting production in protest at changes to manufacturing regulations.
As it tries to close its biggest deal ever -- a $33bn acquisition of Perrigo -- Mylan is now also dealing with an FDA warning letter citing cGMP violations tied to three of its manufacturing facilities in India.